Last reviewed · How we verify
NCT05637645
Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section
NA trial testing Midline Approach in Post-Dural Puncture Headache in 200 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Bahawal Victoria Hospital Bahawalpur |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 200 |
| Start date | 22 November 2022 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 January 2023 |
| Sites | 4 locations across Pakistan |
Drugs / interventions tested
- Midline Approach
- Paramedian Approach
- Taylors approach
Conditions studied
- Post-Dural Puncture Headache — all drugs for Post-Dural Puncture Headache →
- Hypotension — all drugs for Hypotension →
- Spinal Shock — all drugs for Spinal Shock →
- Hematoma — all drugs for Hematoma →
Sponsor
Bahawal Victoria Hospital Bahawalpur
Who can join
Adults 18 to 50, female only, with Post-Dural Puncture Headache or Hypotension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare different approaches of spinal anesthesia in pregnant females who are having cesarean section. The main aim is • Which approach is better in terms of avoiding intraoperative and post operative complications Participants will be given anesthesia by 1. Midline approach 2. paramedian approach 3. Taylors approach
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05637645
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-Dural Puncture Headache
Currently open trials in the same condition.
- NCT06824025 — Comparison of Nebulized Neostigmine/Atropine Versus Lignocaine in Treating Acute Post-dural Puncture Headache Following · EARLY_PHASE1 · recruiting
- NCT07515456 — Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache · NA · recruiting
- NCT06253754 — Pathophysiological Mechanisms and Implication of Treatment in Postural Puncture Headache · recruiting
- NCT06444737 — Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia · NA · recruiting
- NCT05804448 — Effect of Altitude on Postdural Puncture Headache After Caesarean Delivery · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05637645 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bahawal Victoria Hospital Bahawalpur
- Last refreshed: 9 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05637645.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing